Publications by authors named "Greg Anglin"

Claim this Profile
D
Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease.
Garrett R Mullins, Paul Ardayfio, Ivelina Gueorguieva, Greg Anglin, Jason Bailey

Alzheimers Dement (N Y)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
Garrett R Mullins, Michael E Hodsdon, Ying Grace Li, Greg Anglin, Shweta Urva

J Clin Endocrinol Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.
Mary Nilsson, Brenda Crowe, Greg Anglin, Greg Ball, Melvin Munsaka

Stat Biopharm Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.
James M Martinez, Nada Hindiyeh, Greg Anglin, Kavita Kalidas, Michael E Hodsdon

Cephalalgia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers.
Anne M Wolka, Angelyn O Fairchild, Shelby D Reed, Greg Anglin, F Reed Johnson

Ther Innov Regul Sci· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is clearance worth? Patients' stated risk tolerance for psoriasis treatments.
Angelyn O Fairchild, Shelby D Reed, F Reed Johnson, Greg Anglin, Anne M Wolka

J Dermatolog Treat· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.
Michael A Nauck, Jean-Louis Frossard, Jamie S Barkin, Greg Anglin, Ingrid E Hensley

Diabetes Care· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.
Katherine R Tuttle, T Dwight McKinney, Jaime A Davidson, Greg Anglin, Kristine D Harper

Diabetes Obes Metab· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Structured Benefit-Risk Assessments in Marketing Authorization Applications: Lessons Learned.
JuAn Wang, Anne Wolka, Kristin Bullok, Greg Anglin, Christine Radawski

Ther Innov Regul Sci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.
Catherine E Hamelin, Greg Anglin, Charmian A Quigley, Cheri L Deal

J Clin Endocrinol Metab· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
Serge Carrier, Gerald B Brock, Peter J Pommerville, Janey Shin, Greg Anglin

J Sex Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.
Hartmut Porst, Harin Padma-Nathan, François Giuliano, Greg Anglin, Lucio Varanese

Urology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tadalafil on erectile dysfunction in men with diabetes.
Iñigo Sáenz de Tejada, Greg Anglin, James R Knight, Jeffrey T Emmick

Diabetes Care· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.
Gerald B Brock, Chris G McMahon, K K Chen, Timothy Costigan, Wei Shen, Greg Anglin

J Urol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
Charmian A Quigley, Brenda J Crowe, D Greg Anglin, John J Chipman

J Clin Endocrinol Metab· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis